Xuanrong Chen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Cell death & disease

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xuanrong Chen, Yi Shao, Wanqing Wei, Shimiao Zhu, Yang Li, Yutong Chen, Hanling Li, Hao Tian, Guijiang Sun, Yuanjie Niu, Zhiqun Shang
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (10) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Xuanrong Chen, Yi Shao, Wanqing Wei, Shimiao Zhu, Yang Li, Yutong Chen, Hanling Li, Hao Tian, Guijiang Sun, Yuanjie Niu, Zhiqun Shang
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 13 (11) (2022)
Xuanrong Chen, Qianwang Ma, Zhiqun Shang, Yuanjie Niu
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets. NPJ precision oncology 4 (1) (2020)

Xuanrong Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xuanrong Chen